-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Approved as One of the First “Talent Outposts” in the City for 2023
Category:
发布时间：2023-09-08
【概要描述】
Establishing R&D institutions in other regions, attracting high-caliber talent, overcoming technical challenges, and then bringing the resulting innovations back to Shijiazhuang—such entities are known as “talent enclaves.” Recently, the first list of Shijiazhuang’s 2023 “Talent Enclaves” was announced, with seven companies successfully recognized and collectively receiving 3 million yuan in funding. Among them, Jiangsu Bosheng Medical New Materials Co., Ltd., a subsidiary of Shijiazhuang Sihua Pharmaceutical in Jiangsu Province, was designated as a “Talent Enclave” enterprise group under the Shijiazhuang Municipal Government.
Establishing R&D institutions in other regions, attracting high-caliber talent, overcoming technical challenges, and then bringing the resulting innovations back to Shijiazhuang—such entities are known as “talent enclaves.” Recently, the first list of Shijiazhuang’s 2023 “Talent Enclaves” was announced, with seven enterprises successfully recognized and collectively receiving 3 million yuan in funding. Among them, Jiangsu Bosheng Medical New Materials Co., Ltd., a subsidiary of Shijiazhuang Sihua Pharmaceutical in Jiangsu Province, was designated as a “Talent Enclave” enterprise under the Shijiazhuang Municipal “Talent Enclave” program.
Jiangsu Bosheng Medical New Materials Co., Ltd., a controlling subsidiary of Shijiazhuang Sihua Pharmaceutical, serves as the Group’s innovation hub for accelerating industrial transformation and strengthening, extending, and completing the pharmaceutical value chain. The company has established high-level R&D platforms, including the Jiangsu Provincial Bosheng Medical Packaging Materials Engineering Technology Research Center, and is primarily engaged in the systematic R&D of chemical pharmaceutical packaging materials, such as pharmaceutical butyl rubber stoppers (including coated and film-coated stoppers) and multilayer co-extruded infusion films. Headquartered in the High-tech Industrial Development Zone of Shijiazhuang City, Sihua Pharmaceutical conducts R&D on pharmaceutical packaging materials in Jiangsu Province; the resulting innovations are then translated into commercial production at Sihua, thereby establishing a deeply integrated industry–research innovation system. Through continuous technological research and targeted product development, the company has significantly shortened the time required to translate R&D findings into practical applications and has put in place an effective mechanism for sustained innovation and application. This approach to technology transfer has not only enhanced Sihua Pharmaceutical’s capabilities in formulation innovation, technology transfer, and overall R&D excellence, but also provided strong support for attracting talent, sharing innovation resources, and further bolstering the company’s innovative capacity, ensuring that scientific and technological advances are directly applied and implemented in Shijiazhuang.
In 2022, in order to pool talent and intellectual resources, promote exchanges and cooperation in talent and technology, and accelerate the transfer and application of scientific and technological achievements in Shijiazhuang, the city issued the “Detailed Implementation Rules for the Recognition, Management, and Service of ‘Talent Outposts.’” Specifically, legal entities within the administrative jurisdiction of Shijiazhuang—such as governments at all levels, industrial parks, enterprises and public institutions, municipal universities and research institutes, and other research organizations—are permitted to establish or register (including through equity control) innovative service platforms in regions outside the city that are hubs for talent and technology and rich in science and innovation resources. These platforms fall into three categories: “R&D institutions,” “crowd-creation spaces,” and “talent recruitment workstations.” The city will recognize “talent outposts” through a process that includes application submission, eligibility review, evaluation and on-site inspection, and public announcement of the results. Once recognized, these “talent outposts” will be subject to a two-year management period, during which they will receive financial support primarily earmarked for attracting and cultivating talent, conducting project R&D, and facilitating the commercialization of research outcomes.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091